Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Covington
McKinsey
Queensland Health
Dow
Daiichi Sankyo
QuintilesIMS
Julphar

Generated: May 26, 2018

DrugPatentWatch Database Preview

FLAREX Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Flarex, and when can generic versions of Flarex launch?

Flarex is a drug marketed by Novartis Pharms Corp and is included in one NDA.

The generic ingredient in FLAREX is fluorometholone acetate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fluorometholone acetate profile page.
Drug patent expirations by year for FLAREX
Pharmacology for FLAREX
Synonyms for FLAREX
(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-17-hydroxy-2,8,15-trimethyl-5-oxotetracyclo[8.7.0.0?,?.0??,??]heptadeca-3,6-dien-14-yl acetate
(1R,2S,8S,10S,11S,14R,15S,17S)-14-ACETYL-1-FLUORO-17-HYDROXY-2,8,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL ACETATE
(6|A,11|A)-17-(Acetyloxy)-9-fluoro-11-hydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-9-fluoro-11-hydroxy-6-methyl-3,20-dioxopregna-1,4-dien-17-yl acetate
[(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11-hydroxy-6,10,13-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate
17-(Acetyloxy)-9-fluoro-11beta-hydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
3801-06-7
6|A-Methyl-9|A-fluoro-17-acetoxy-21-deoxyprednisolone
6alpha-Methyl-9alpha-fluoro-17-acetoxy-21-deoxyprednisolone
801F067
9-fluoro-11beta-hydroxy-6alpha-methyl-3,20-dioxopregna-1,4-dien-17-yl acetate
9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 17-acetate
9I50C3I3OK
AB00641960_02
AB2000749
AC-2172
AC1L65X1
AC1Q5WXS
AI3-52814
AKOS025401542
API0008905
BC226380
C14629
C24H31FO5
CHEBI:78354
CHEMBL1201064
CTK8F9818
D04221
DTXSID20191424
Eflone
EINECS 223-270-3
Fluorometholone 17-acetate
FLUOROMETHOLONE ACETATE
Fluorometholone acetate (USAN)
Fluorometholone acetate [USAN:USP]
MolPort-005-943-419
NCI60_004118
NSC 47438
NSC-47438
NSC47438
Oxylone acetate
PL039261
Pregna-1,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-6-methyl-, (6.alpha.,11.beta.)-
Pregna-1,20-dione, 9-fluoro-11.beta.,17-dihydroxy-6.alpha.-methyl-, 17-acetate
Pregna-1,4-diene-3,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-6-methyl-, (6alpha,11beta)-
Progesterone,17-dihydroxy-6.alpha.-methyl-,17-acetate
s4228
SC-66119
SCHEMBL43184
U 17,323
U 17323
U-17,323
U-17323
UNII-9I50C3I3OK
ZINC4213357

US Patents and Regulatory Information for FLAREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp FLAREX fluorometholone acetate SUSPENSION/DROPS;OPHTHALMIC 019079-001 Feb 11, 1986 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Citi
Healthtrust
Fish and Richardson
Julphar
Covington
AstraZeneca
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.